U.S. Food and Drug Administration

New Policies and Procedures Regarding Transparency and Public Disclosure for FDA Advisory Committees

Topics on this Page


The Food and Drug Administration has announced several new policies and procedures to strengthen its management of FDA advisory committees. They are detailed in four final guidance documents and one draft guidance. Our goal is to make our process for seeking advice from independent experts as open, public, and transparent as possible, so that we maintain the highest public confidence in that process.

New Guidance Documents

News Release

More on Advisory Committee Improvements

rule link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page